Optical biosensor developer Profusa closes $45M Series C financing round

Aug. 24, 2018
The company plans to use this financing to accelerate the development of its transformative glucose biosensor technology.

Tissue-integrating optical biosensor maker Profusa (South San Francisco, CA) has raised more than $45 million in a Series C financing. The company plans to use the proceeds from this financing to advance the commercialization of its Lumee oxygen platform for continuous, real-time monitoring of tissue oxygen, and to accelerate the development of its transformative glucose biosensor technology.

The company's Lumee oxygen platform is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. According to the company, it comprises a ~5-mm-long, 500 µm flexible fiber made of a porous smart gel that is biologically compatible with tissues for continuous montioring—its light-emitting molecule emits a fluorescence signal in the presence of, for example, oxygen, glucose, and lactate. Then, a separate optical reader reads that fluorescent signal and sends excitation light through the skin to the biosensor to perform biochemical measurement.

Potential applications for the platform include monitoring of compromised tissue, such as peripheral artery disease (PAD) that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds, such as diabetic ulcers and pressure sores that do not heal properly; sleep apnea; chronic obstructive pulmonary disease; and reconstructive surgery. Currently, the platform is CE-Marked for use in the European Union.

New investors VMS Investment Group, Tasly Pharmaceutical Group, and Maxim Integrated Ventures joined existing investors 3E Bioventures Capital and Atinum Investment in this latest round of funding.

For more information, please visit profusa.com.

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)

Sponsored Recommendations

Request a quote: Micro 3D Printed Part or microArch micro-precision 3D printers

April 11, 2024
See the results for yourself! We'll print a benchmark part so that you can assess our quality. Just send us your file and we'll get to work.

Request a free Micro 3D Printed sample part

April 11, 2024
The best way to understand the part quality we can achieve is by seeing it first-hand. Request a free 3D printed high-precision sample part.

How to Tune Servo Systems: The Basics

April 10, 2024
Learn how to tune a servo system using frequency-based tools to meet system specifications by watching our webinar!

Precision Motion Control for Sample Manipulation in Ultra-High Resolution Tomography

April 10, 2024
Learn the critical items that designers and engineers must consider when attempting to achieve reliable ultra-high resolution tomography results here!

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!